» Articles » PMID: 34852813

Diagnosis Experiences from 50 Hepatitis B Patients in Chongqing, China: a Qualitative Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2021 Dec 2
PMID 34852813
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to provide recommendations for reducing the impact of hepatitis B infection on patients with chronic hepatitis B by describing their experiences during the diagnosis process.

Methods: We conducted face-to-face interviews with 50 hepatitis B patients recruited by convenient sampling from an infectious diseases department of a teaching hospital in Chongqing, China from July to August 2019. Thematic analysis framework included interviewees' social demographic characteristics, diagnosis approach, signs and symptoms before diagnosis, feelings after diagnosis, and doctor's instructions.

Results: Most patients first detected hepatitis B through various types of physical examinations when the patients were asymptomatic or had only mild symptoms. Most patients were shocked, scared, or overwhelmed when they were diagnosed with hepatitis B. They were able to remember the doctor's instructions about maintaining a healthy lifestyle, but not impressed by the doctor's advice about regular follow-up liver function tests. The lack of regular follow-up has caused irreversible damage to some patients.

Conclusions: Most patients are passively diagnosed with hepatitis B due to their lack of awareness on active hepatitis B prevention. Patients need professional mental health care to overcome the negative emotions that following the diagnosis. Physicians' instruction should emphasize the importance of regular follow-up liver function tests in addition to a healthy lifestyle.

Citing Articles

Assessing ChatGPT as a Medical Consultation Assistant for Chronic Hepatitis B: Cross-Language Study of English and Chinese.

Wang Y, Chen Y, Sheng J JMIR Med Inform. 2024; 12:e56426.

PMID: 39115930 PMC: 11342014. DOI: 10.2196/56426.


Development and validation of HBV surveillance models using big data and machine learning.

Dong W, Da Roza C, Cheng D, Zhang D, Xiang Y, Seto W Ann Med. 2024; 56(1):2314237.

PMID: 38340309 PMC: 10860422. DOI: 10.1080/07853890.2024.2314237.

References
1.
Eltawil K, Berry R, Abdolell M, Molinari M . Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre. HPB (Oxford). 2012; 14(3):162-70. PMC: 3371198. DOI: 10.1111/j.1477-2574.2011.00420.x. View

2.
Jaka H, Mshana S, Rambau P, Masalu N, Chalya P, Kalluvya S . Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting. World J Surg Oncol. 2014; 12:246. PMC: 4121298. DOI: 10.1186/1477-7819-12-246. View

3.
Nayagam S, Sicuri E, Lemoine M, Easterbrook P, Conteh L, Hallett T . Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries. BMC Infect Dis. 2017; 17(Suppl 1):692. PMC: 5688395. DOI: 10.1186/s12879-017-2778-x. View

4.
Niederau C . Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit. World J Gastroenterol. 2014; 20(33):11595-617. PMC: 4155353. DOI: 10.3748/wjg.v20.i33.11595. View

5.
Ang L, Cutter J, James L, Goh K . Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review. Vaccine. 2013; 32(1):103-10. DOI: 10.1016/j.vaccine.2013.10.057. View